Results of interleukin-2-based treatment in advanced melanoma: a case record-based analysis of 631 patients.

Keilholz, U; Conradt, C; Legha, S S; Khayat, D; Scheibenbogen, C; Thatcher, N; Goey, S H; Gore, M; Dorval, T; Hancock, B; Punt, C J; Dummer, R; Avril, M F; Bröcker, E B; Benhammouda, A; Eggermont, A M; Pritsch, M

Keilholz, U; Conradt, C; Legha, S S; Khayat, D; Scheibenbogen, C; Thatcher, N; Goey, S H; Gore, M; Dorval, T; Hancock, B; Punt, C J; Dummer, R; Avril, M F; Bröcker, E B; Benhammouda, A; Eggermont, A M; Pritsch, M.

Affiliation

Keilholz U; Department of Medicine III (Hematology/Oncology/Transfusion Medicine), University Hospital Benjamin Franklin, Free University Berlin, Germany. Keilholz@ukbf.fu-berlin.de

J Clin Oncol ; 16(9): 2921-9, 1998 Sep.

Article in En | MEDLINE | ID: mdl-9738559

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Interleukin-2 / Melanoma Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies / Systematic_reviews Limits: Adult / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 1998 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos

Search on Google

Add to My VHL

XML

PubMed Links